Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • 言語
  • クリニックポータル
  • お問い合わせはこちらへ
  • お問い合わせはこちらへ
  • Part of brands: |
アイジェノミクス・ジャパンアイジェノミクス・ジャパン
  • Part of brands: |
  • PATIENT JOURNEY(患者様向け)
    • 妊娠前
    • 体外受精をはじめたら
    • 妊娠中
    • 出産後
  • 医療関係者向け
    • EndomeTRIO検査
    • ERA検査
    • EMMA検査
    • ALICE検査
    • PGT-A検査
    • POC検査
    • PGT-M検査
  • ニュース・ブログ
  • Academy
Home > Genetic Solutions

CGT: Carrier Genetic Test

CGT is an advanced carrier genetic test before pregnancy to determine the risk of having a chind with a genetic disease.

  • Technical overview
  • Disorders
  • Gamete banks
  • Documentation
  • Scientific evidence
  • Tools
  • I’m not a health specialist

The global prevalence of genetic diseases is 10 in 1000 newborn infants.

[*] ACOG Committee on Genetics
This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Genetics in collaboration with committee members Britton Rink, MD;
Stephanie Romero, MD; Joseph R. Biggio Jr, MD; Devereux N. Saller Jr, MD; and Rose Giardine, MS.

84% of individuals are carriers of at least one condition.

[*] ACOG Committee on Genetics
This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Genetics in collaboration with committee members Britton Rink, MD;
Stephanie Romero, MD; Joseph R. Biggio Jr, MD; Devereux N. Saller Jr, MD; and Rose Giardine, MS.

The average person is carrier of 2 disease-causing mutations.

[*] ACOG Committee on Genetics
This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Genetics in collaboration with committee members Britton Rink, MD;
Stephanie Romero, MD; Joseph R. Biggio Jr, MD; Devereux N. Saller Jr, MD; and Rose Giardine, MS.

Inherited disorders represent 20% of the causes of infant mortality in developed countries

[*] ACOG Committee on Genetics
This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Genetics in collaboration with committee members Britton Rink, MD;
Stephanie Romero, MD; Joseph R. Biggio Jr, MD; Devereux N. Saller Jr, MD; and Rose Giardine, MS.

Request information

We answer in 48 hours lorem ipsum sis amet

Write us

Course CGT

Access the e-learning portal to attend the course

Order now
About CGT

What is a single gene disorder?

A single gene disorder it’s a hereditary disorder caused by the presence of a mutation, or mutations, in a particular gene. Gene disorders can’t be cured, but they can be prevented.

It identifies couples in which both partners are carriers. In this way it prevents serious genetic disorders in their offspring.

It analises disorders such as Cystic Fibrosis, Spinal Muscular Atrophy, Fragile-X Syndrome amongst others by NGS.

If both partners carry a mutation in the same gene, they will be at high risk of having an affected child. In these cases, there are options for conceiving healthy children, like Preimplantation Genetic Diagnosis or gamete donation. It’s also possible to use prenatal diagnosis after conceiving naturally.

Most carriers of genetic mutations don’t have a family history of these disorders

Test features

  • Study on more than 6,000 mutations associated with over 600 genetic disorders.
  • Genetic counseling for patients and specialists.
  • Availability of a specific module for gamete donation programs.
  • Genetic screening test based on massive sequencing (NGS) and clinically validated.

Who is this test for?

For any couple who wants to form a family to know the risk of transmitting hereditary disorders to their children

Before an assisted reproduction treatment

Before a treatment with donor sperm or eggs.

Which disorders are studied?

It analises disorders such as Cystic Fibrosis, Spinal Muscular Atrophy,
Fragile-X Syndrome amongst others.

CGT 600 Related publications

What’s the procedure?

The test requires 5 ml of blood collected in an EDTA tube which is transported at room temperatur and with the recommended protection: a padded envelope or in the pack sent in the kit. The sample should be sent within a maximum of 48 hours.

How is a carrier screening performed?

Doctor prescibes test
Blood sample
DN Aanlaysis by NGS
Mutation report

How do we interpret the results?

+ POSITIVE

If the tested person carries a mutation in a particular gene, the test should be carried out in the other member of the couple.

- NEGATIVE

A negative result indicates that the person doesn’t carry any of the mutations studied. There is still residual risk of carrying another mutation not analyzed by the test.

Application of the test to the donor bank

At Igenomix we offer the test to infertility clinic patients receiving a sperm or egg donation. The joint study of both the donor and recipient significantly reduces the possibility of having a baby affected by the disorders studied.

Why choose the Igenomix Carrier Screening Test?

39,000

TESTS PERFORMED

53

PARTNER CLINICS

14

LABS IN 9 COUNTRIES

How can I explain this service to my patients

Non-technical explanation for your patients Brochure for your patients Product sheet
Documentation & Resources

For printing or to download

パンフレット

ダウンロード

パンフレット

ダウンロード

パンフレット

ダウンロード

Tools:

TOOLS

Calculator

Sociis natoque penatibus et magnis dis parturient montes.

Download
Scientific evidence

Relevant related studies:

Vafai, S. B. & Mootha, V. K.

Mitochondrial disorders as windows into an ancient organelle

Nature 491, 374–383 (2012)

Read
Vafai, S. B. & Mootha, V. K.

Mitochondrial disorders as windows into an ancient organelle

Nature 491, 374–383 (2012)

Read
Methodology
CGT for gamete banks

 Lorem ipsum dolor est

The Carrier Screening Test from Igenomix provides a powerful and exclusive computerized
tool called CGT Match. This software allows genetically matched gametes to be selected for a
recipient after analyzing the egg or sperm bank of an assisted reproduction clinic.

Difference between a genetically tesed banck and a non tested bank

1 / 20

A banck whis is not genetically tested, uses eggs with a hight risk of transmitting a genetic disease

TESTED

1 / 110,000

A banck whis is not genetically tested, uses eggs with a hight risk of transmitting a genetic disease

NON TESTED
Technical information

Test limitations

  • The sensitivity of the test is 98%.
  • We only analyze genes on the list available, reporting results based on knowledge current at the time of testing. Therefore, only genes included in this list will be detected.
  • The method is based on analysis by massive parallel sequencing and bioinformatics, studying all the exons of the genes included on our gene list. This includes adjacent intronic regions before or after position +5 and -5. Variants located outside the gene regions studied, such as gene-expression regulatory regions or intronic regions before or after position +5 and -5 are not detected.
  • No inversions, deletions, or duplications over 20 nucleotides long that are not referred to in the list available, are studied.
  • Germ mosaics (mutations only present in gametes) are not detected by this analysis because the DNA material studied is obtained from a blood sample.
  • A negative result for the genes indicated does not exclude the possibility that a de novo mutation may appear in the offspring.

If you´re a little lost with this technical information...

Can we help you?

I’m not a health specialist

アイジェノミクスとあなた

アイジェノミクスは生殖遺伝子検査サービスに特化した医学的検査の研究所で、不妊がもはや不可能な障壁でなくなる世界の実現に向け取り組んでいます。世界の医療機関と不妊専門医とともに、私たちは、妊娠を望むカップルの人生を変えるヒトの生殖を研究しています。

Learn more about Igenomix
email

Subscribe to
our newsletter

[gravityform id=1 title=false description=false ajax=true tabindex=49]

Learn about
genetics

Related courses and learning paths

Lorem ipsum sis amet

Sociis natoque penatibus et
magnis dis parturient montes,
nascetur ridiculus mus. Nam
fermentum, nulla luctus pharetra
vulputate, felis tellus mollis orci,
sed rhoncus pronin sapien nunc
accuan eget.

More information

Lorem ipsum sis amet

Sociis natoque penatibus et
magnis dis parturient montes,
nascetur ridiculus mus. Nam
fermentum, nulla luctus pharetra
vulputate, felis tellus mollis orci,
sed rhoncus pronin sapien nunc
accuan eget.

More information

不明点・ご質問はございますか?

お問い合わせはこちらへ 公式LINEにて、患者さんからのご質問を受け付けています。

Igenomix related services

Proain agravida dolor sit amet lacus accumsan et viverra justo commodo

PGS

Preimplantation Genetic Screening

Early risk detection of hereditary breast and ovarian cancer

More information

Block "788" not found

PATIENT JOURNEY(患者様向け)

検査案内
お悩みの患者様

医療関係者様向け

検査案内
ウェブセミナー&説明会

企業情報

アイジェノミクスについて
グローバル拠点
ニュース・コラム
採用情報

株式会社 アイジェノミクス・ジャパン

〒105-0011
東京都港区芝公園1-3-1
留園ビル8F

土日祝日休業、営業時間:9時~18時

患者様からのお問合せはLINE公式アカウントへ

Igenomix Japan, K.K.

Ryuen Building 8F, 1-3-1 Shibakoen,
Minato-ku, Tokyo 105-0011

  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
言語

[2024] © Igenomix プライバシーポリシークッキーポリシー

ソーシャルメディアポリシー

お問い合わせ


  • reCAPTCHA demo: Simple page

  • PATIENT JOURNEY(患者様向け)
    • 妊娠前
    • 体外受精をはじめたら
    • 妊娠中
    • 出産後
  • 医療関係者向け
    • EndomeTRIO検査
    • ERA検査
    • EMMA検査
    • ALICE検査
    • PGT-A検査
    • POC検査
    • PGT-M検査
  • ニュース・ブログ
  • Academy
  • 言語
  • クリニックポータル